Cargando…
Subcutaneous Testosterone Is Effective and Safe as Gender-Affirming Hormone Therapy in Transmasculine and Gender-Diverse Adolescents and Young Adults: A Single Center's 8-Year Experience
Purpose: To describe our Center's 8-year experience with subcutaneous testosterone (SC-T) as gender-affirming hormone therapy (GAHT) in transmasculine and gender-diverse (TM/GD) youth. Methods: An Institutional Review Board (IRB)-approved retrospective study for 119 TM/GD subjects who started S...
Autores principales: | Laurenzano, Sarah E., Newfield, Ron S., Lee, Euyhyun, Marinkovic, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664110/ https://www.ncbi.nlm.nih.gov/pubmed/34988290 http://dx.doi.org/10.1089/trgh.2020.0103 |
Ejemplares similares
-
OR05-4 Case Series of Transmasculine Adolescents Who Developed Polycythemia on Gender Affirming Hormone Therapy
por: Latysheva, Natalya
Publicado: (2022) -
Barriers to Gender-affirming Surgery Consultations in a Sample of Transmasculine Patients in Boston, Mass.
por: Tabaac, Ariella R., et al.
Publicado: (2020) -
Localized Rhabdomyolysis Associated With Testosterone Enanthate for Gender-Affirming Hormonal Therapy
por: Reddy, Rashmi, et al.
Publicado: (2022) -
An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy
por: Maheshwari, Arvind, et al.
Publicado: (2021) -
Health and Access to Gender-Affirming Care During COVID-19: Experiences of transmasculine individuals and men assigned female sex at birth
por: D’Angelo, Alexa B., et al.
Publicado: (2021)